Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the US Adult Population

被引:958
作者
Colilla, Susan [1 ]
Crow, Ann [2 ]
Petkun, William [3 ]
Singer, Daniel E. [4 ,5 ]
Simon, Teresa [6 ]
Liu, Xianchen [7 ]
机构
[1] Bristol Myers Squibb Co, Global Hlth Econ & Outcomes Res, Princeton, NJ USA
[2] Bristol Myers Squibb Co, Global Epidemiol Forecasting, Princeton, NJ USA
[3] Bristol Myers Squibb Co, Global Med Affairs, Princeton, NJ 08540 USA
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
[5] Harvard Univ, Sch Med, Boston, MA USA
[6] Bristol Myers Squibb Co, Global Pharmacovigilance & Epidemiol, New York, NY 10154 USA
[7] Pfizer Inc, Global Hlth Econ & Outcomes Res, New York, NY USA
关键词
PROJECTIONS; RISK;
D O I
10.1016/j.amjcard.2013.05.063
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Estimates and projections of diagnosed incidence and prevalence of atrial fibrillation (AF) in the United States have been highly inconsistent across published studies. Although it is generally acknowledged that AF incidence and prevalence are increasing due to growing numbers of older people in the U.S. population, estimates of the rate of expected growth have varied widely. Reasons for these variations include differences in study design, covered time period, birth cohort, and temporal effects, as well as improvements in AF diagnosis due to increased use of diagnostic tools and health care awareness. The objective of this study was to estimate and project the incidence and prevalence of diagnosed AF in the United States out to 2030. A large health insurance claims database for the years 2001 to 2008, representing a geographically diverse 5% of the U.S. population, was used in this study. The trend and growth rate in AF incidence and prevalence was projected by a dynamic age-period cohort simulation progression model that included all diagnosed AF cases in future prevalence projections regardless of follow-up treatment, as well as those cases expected to be chronic in nature. Results from the model showed that AF incidence will double, from 1.2 million cases in 2010 to 2.6 million cases in 2030. Given this increase in incidence, AF prevalence is projected to increase from 5.2 million in 2010 to 12.1 million cases in 2030. The effect of uncertainty in model parameters was explored in deterministic and probabilistic sensitivity analyses. Variability in future trends in AF incidence and recurrence rates has the greatest impact on the projected estimates of chronic AF prevalence. It can be concluded that both incidence and prevalence of AF are likely to rise from 2010 to 2030, but there exists a wide range of uncertainty around the magnitude of future trends. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:1142 / 1147
页数:6
相关论文
共 10 条
[1]   Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study [J].
Go, AS ;
Hylek, EM ;
Phillips, KA ;
Chang, YC ;
Henault, LE ;
Selby, JV ;
Singer, DE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (18) :2370-2375
[2]   Challenges in the classification of atrial fibrillation [J].
Lubitz, Steven A. ;
Benjamin, Emelia J. ;
Ruskin, Jeremy N. ;
Fuster, Valentin ;
Ellinor, Patrick T. .
NATURE REVIEWS CARDIOLOGY, 2010, 7 (08) :451-459
[3]   Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence [J].
Miyasaka, Yoko ;
Barnes, Marion E. ;
Gersh, Bernard J. ;
Cha, Stephen S. ;
Bailey, Kent R. ;
Abhayaratna, Walter P. ;
Seward, James B. ;
Tsang, Teresa S. M. .
CIRCULATION, 2006, 114 (02) :119-125
[4]   Increasing Prevalence of Atrial Fibrillation and Flutter in the United States [J].
Naccarelli, Gerald V. ;
Varker, Helen ;
Lin, Jay ;
Schulman, Kathy L. .
AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (11) :1534-1539
[5]   Independent Contribution of Diabetes to Increased Prevalence and Incidence of Atrial Fibrillation [J].
Nichols, Gregory A. ;
Reinier, Kyndaron ;
Chugh, Sumeet S. .
DIABETES CARE, 2009, 32 (10) :1851-1856
[6]   Incidence and Prevalence of Atrial Fibrillation and Associated Mortality Among Medicare Beneficiaries, 1993-2007 [J].
Piccini, Jonathan P. ;
Hammill, Bradley G. ;
Sinner, Moritz F. ;
Jensen, Paul N. ;
Hernandez, Adrian F. ;
Heckbert, Susan R. ;
Benjamin, Emelia J. ;
Curtis, Lesley H. .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2012, 5 (01) :85-U162
[7]   Bayesian probabilistic population projections for all countries [J].
Raftery, Adrian E. ;
Li, Nan ;
Sevcikova, Hana ;
Gerland, Patrick ;
Heilig, Gerhard K. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (35) :13915-13921
[8]   Update on atrial fibrillation: Part I [J].
Savelieva, Irina ;
Camm, John .
CLINICAL CARDIOLOGY, 2008, 31 (02) :55-62
[9]   Association of Body Mass Index, Diabetes, Hypertension, and Blood Pressure Levels with Risk of Permanent Atrial Fibrillation [J].
Thacker, Evan L. ;
McKnight, Barbara ;
Psaty, Bruce M. ;
Longstreth, W. T., Jr. ;
Dublin, Sascha ;
Jensen, Paul N. ;
Newton, Katherine M. ;
Smith, Nicholas L. ;
Siscovick, David S. ;
Heckbert, Susan R. .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 (02) :247-253
[10]  
U.S. Census Bureau, 2012 STAT ABSTR POP